Beta-carotene

β-胡萝卜素

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameBeta-carotene
Drug Alias Name倍他胡萝卜素β-caroteneβ 胡萝卜素BeetakaroteeniBetakaroten +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors bindersRetinoid X receptor binders
TargetsRetinoid X receptorRetinoic acid receptors
Therapy Area/IndicationsVitamin A DeficiencyAvitaminosisProtoporphyria, Erythropoietic
Global Approved IndicationsAvitaminosis
Approved Indications in ChinaAvitaminosis
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Sine Yanan Pharmaceutical Co Ltd
Inactive CompaniesTufts UniversityF. Hoffmann-La Roche Ltd
Active IndicationsAvitaminosis
Inactive IndicationsVitamin A DeficiencyProtoporphyria, Erythropoietic

Other Information

ATC CodeA11CA02D02BB01
Related LinksWikipediaKEGG